Authors/Disclosures
|
Rita Kaspar
|
No disclosure on file |
|
Philippine Dana Peralta, MD
(US Air Force)
|
No disclosure on file |
|
Hugh D. Allen
(Nationwide Childrens)
|
No disclosure on file |
|
|
No disclosure on file |
|
John T. Kissel, MD, FAAN
|
Dr. Kissel has nothing to disclose. |
|
Kevin M. Flanigan, MD, FAAN
(Nationwide CHildrens Hospital)
|
Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Armatus. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. The institution of Dr. Flanigan has received research support from Ultragenyx . The institution of Dr. Flanigan has received research support from Solid Biosciences. The institution of Dr. Flanigan has received research support from Dyne Therapeutics. The institution of Dr. Flanigan has received research support from Avidity. |
|
Jing Wang, MD
(Children's Hospital Of Philadelphia)
|
No disclosure on file |
|
Jerry R. Mendell, MD, FAAN
(The Research Institute at Nationwide Children's Hospital)
|
Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta. |
|
|
No disclosure on file |